- •Preface and Acknowledgments
- •Contents
- •Contributors
- •1: Embryology for Urologists
- •Introduction
- •Renal Development
- •Pronephros
- •Mesonephros
- •Metanephros
- •Development of the Collecting System
- •Critical Steps in Further Development
- •Anomalies of the Kidney
- •Renal Agenesis
- •Renal Aplasia
- •Renal Hypoplasia
- •Renal Ectopia
- •Renal Fusion
- •Ureteral Development
- •Anomalies of Origin
- •Anomalies of Number
- •Incomplete Ureteral Duplication
- •Complete Ureteral Duplication
- •Ureteral Ectopia
- •Embryology of Ectopia
- •Clinical Correlation
- •Location of Ectopic Ureteral Orifices – Male (in Descending Order According to Incidence)
- •Symptoms
- •Ureteroceles
- •Congenital Ureteral Obstruction
- •Pipestem Ureter
- •Megaureter-Megacystis Syndrome
- •Prune Belly Syndrome
- •Vascular Ureteral Obstructions
- •Division of the Urogenital Sinus
- •Bladder Development
- •Urachal Anomalies
- •Cloacal Duct Anomalies
- •Other Bladder Anomalies
- •Bladder Diverticula
- •Bladder Extrophy
- •Gonadal Development
- •Testicular Differentiation
- •Ovarian Differentiation
- •Gonadal Anomalies
- •Genital Duct System
- •Disorders of Testicular Function
- •Female Ductal Development
- •Prostatic Urethral Valves
- •Gonadal Duct Anomalies
- •External Genital Development
- •Male External Genital Development
- •Female External Genital Development
- •Anomalies of the External Genitalia
- •References
- •2: Gross and Laparoscopic Anatomy of the Upper Urinary Tract and Retroperitoneum
- •Overview
- •The Kidneys
- •The Renal Vasculature
- •The Renal Collecting System
- •The Ureters
- •Retroperitoneal Lymphatics
- •Retroperitoneal Nerves
- •The Adrenal Glands
- •References
- •3: Gross and Laparoscopic Anatomy of the Lower Urinary Tract and Pelvis
- •Introduction
- •Female Pelvis
- •Male Pelvis
- •Pelvic Floor
- •Urinary Bladder
- •Urethra
- •Male Urethra
- •Female Urethra
- •Sphincter Mechanisms
- •The Bladder Neck Component
- •The Urethral Wall Component
- •The External Urethral Sphincter
- •Summary
- •References
- •4: Anatomy of the Male Reproductive System
- •Testis and Scrotum
- •Spermatogenesis
- •Hormonal Regulation of Spermatogenesis
- •Genetic Regulation of Spermatogenesis
- •Epididymis and Ductus Deferens
- •Accessory Sex Glands
- •Prostate
- •Seminal Vesicles
- •Bulbourethral Glands
- •Penis
- •Erection and Ejaculation
- •References
- •5: Imaging of the Upper Tracts
- •Anatomy of the Upper Tracts and Introduction to Imaging Modalities
- •Introduction
- •Renal Upper Tract Basic Anatomy
- •Modalities Used for Imaging the Upper Tracts
- •Ultrasound
- •Radiation Issues
- •Contrast Issues
- •Renal and Upper Tract Tumors
- •Benign Renal Tumors
- •Transitional Cell Carcinoma
- •Renal Mass Biopsy
- •Renal Stone Disease
- •Ultrasound
- •Plain Radiographs and IVU
- •Renal Cystic Disease
- •Benign Renal Cysts
- •Hereditary Renal Cystic Disease
- •Complex Renal Cysts
- •Renal Trauma
- •References
- •Introduction
- •Pathophysiology
- •Susceptibility and Resistance
- •Epidemiological Breakpoints
- •Clinical Breakpoints
- •Pharmacodynamic Parameters
- •Pharmacokinetic Parameters
- •Fosfomycin
- •Nitrofurantoin
- •Pivmecillinam
- •b-Lactam-Antibiotics
- •Penicillins
- •Cephalosporins
- •Carbapenems
- •Aminoglycosides
- •Fluoroquinolones
- •Trimethoprim, Cotrimoxazole
- •Glycopeptides
- •Linezolid
- •Conclusion
- •References
- •7: An Overview of Renal Physiology
- •Introduction
- •Body Fluid Compartments
- •Regulation of Potassium Balance
- •Regulation of Acid–Base Balance
- •Diuretics
- •Suggested Reading
- •8: Ureteral Physiology and Pharmacology
- •Ureteral Anatomy
- •Modulation of Peristalsis
- •Ureteral Pharmacology
- •Conclusion
- •References
- •Introduction
- •Afferent Signaling Pathways
- •Efferent Signaling
- •Parasympathetic Nerves
- •Sympathetic Nerves
- •Vesico-Spinal-Vesical Micturition Reflex
- •Peripheral Targets
- •Afferent Signaling Mechanisms
- •Urothelium
- •Myocytes
- •Cholinergic Receptors
- •Muscarinic Receptors
- •Nicotinic Receptors
- •Adrenergic Receptors (ARs)
- •a-Adrenoceptors
- •b-Adrenoceptors
- •Transient Receptor Potential (TRP) Receptors
- •Phosphodiesterases (PDEs)
- •CNS Targets
- •Opioid Receptors
- •Serotonin (5-HT) Mechanisms
- •g-Amino Butyric Acid (GABA) Mechanisms
- •Gabapentin
- •Neurokinin and Neurokinin Receptors
- •Summary
- •References
- •10: Pharmacology of Sexual Function
- •Introduction
- •Sexual Desire/Arousal
- •Endocrinology
- •Steroids in the Male
- •Steroids in the Female
- •Neurohormones
- •Neurotransmitters
- •Dopamine
- •Serotonin
- •Pharmacological Strategies
- •CNS Drugs
- •Enzyme-inducing Antiepileptic Drugs
- •Erectile Function
- •Ejaculatory Function
- •Premature Ejaculation
- •Abnormal Ejaculation
- •Conclusions
- •References
- •Epidemiology
- •Calcium-Based Urolithiasis
- •Uric Acid Urolithiasis
- •Infectious Urolithiasis
- •Cystine-Based Urolithiasis
- •Aims
- •Who Deserves Metabolic Evaluation?
- •Metabolic Workup for Stone Producers
- •Medical History and Physical Examination
- •Stone Analysis
- •Serum Chemistry
- •Urine Evaluation
- •Urine Cultures
- •Urinalysis
- •Twenty-Four Hour Urine Collections
- •Radiologic Imaging
- •Medical Management
- •Conservative Management
- •Increased Fluid Intake
- •Citrus Juices
- •Dietary Restrictions
- •Restricted Oxalate Diet
- •Conservative Measures
- •Selective Medical Therapy
- •Absorptive Hypercalciuria
- •Thiazide
- •Orthophosphate
- •Renal Hypercalciuria
- •Primary Hyperparathyroidism
- •Hyperuricosuric Calcium Oxalate Nephrolithiasis
- •Enteric Hyperoxaluria
- •Hypocitraturic Calcium Oxalate Nephrolithiasis
- •Distal Renal Tubular Acidosis
- •Chronic Diarrheal States
- •Thiazide-Induced Hypocitraturia
- •Idiopathic Hypocitraturic Calcium Oxalate Nephrolithiasis
- •Hypomagnesiuric Calcium Nephrolithiasis
- •Gouty Diathesis
- •Cystinuria
- •Infection Lithiasis
- •Summary
- •References
- •12: Molecular Biology for Urologists
- •Introduction
- •Inherited Changes in Cancer Cells
- •VEGR and Cell Signaling
- •Targeting mTOR
- •Conclusion
- •References
- •13: Chemotherapeutic Agents for Urologic Oncology
- •Introduction
- •Bladder Cancer
- •Muscle Invasive Bladder Cancer
- •Metastatic Bladder Cancer
- •Conclusion
- •Prostate Cancer
- •Other Chemotherapeutic Drugs or Combinations for Treating HRPC
- •Conclusion
- •Renal Cell Carcinoma
- •Chemotherapy
- •Immunotherapy
- •Angiogenesis Inhibitor Drugs
- •Conclusion
- •Testicular Cancer
- •Stage I Seminoma
- •Stage I non-seminomatous Germ Cell Tumours (NSGCT)
- •Metastatic Germ Cell Tumours
- •Low-Volume Metastatic Disease (Stage II A/B)
- •Advanced Metastatic Disease
- •Salvage Chemotherapy for Relapsed or Refractory Disease
- •Conclusion
- •Penile Cancer
- •Side Effects of Chemotherapy
- •Conclusion
- •References
- •14: Tumor and Transplant Immunology
- •Antibodies
- •Cytotoxic and T-helper Cells
- •Immunosuppression
- •Induction Therapy
- •Maintenance Therapy
- •Rejection
- •Posttransplant Lymphoproliferative Disease
- •Summary
- •References
- •15: Pathophysiology of Renal Obstruction
- •Causes of Renal Obstruction
- •Effects on Prenatal Development
- •Prenatal Hydronephrosis
- •Spectrum of Renal Abnormalities
- •Renal Functional Changes
- •Renal Growth/Counterbalance
- •Vascular Changes
- •Inflammatory Mediators
- •Glomerular Development Changes
- •Mechanical Stretch of Renal Tubules
- •Unilateral Versus Bilateral
- •Limitations of Animal Models
- •Future Research
- •Issues in Patient Management
- •Diagnostic Imaging
- •Ultrasound
- •Intravenous Urography
- •Antegrade Urography and the Whitaker Test
- •Nuclear Renography
- •Computed Tomography
- •Magnetic Resonance Urography
- •Hypertension
- •Postobstructive Diuresis
- •References
- •Introduction
- •The Normal Lower Urinary Tract
- •Anatomy
- •Storage Function
- •Voiding Function
- •Neural Control
- •Symptoms
- •Flow Rate and Post-void Residual
- •Voiding Cystometry
- •Male
- •Female
- •Neurourology
- •Conclusions
- •References
- •17: Urologic Endocrinology
- •The Testis
- •Normal Androgen Metabolism
- •Epidemiological Aspects
- •Prostate
- •Brain
- •Muscle Mass and Adipose Tissue
- •Bones
- •Ematopoiesis
- •Metabolism
- •Cardiovascular System
- •Clinical Assessment
- •Biochemical Assessment
- •Treatment Modalities
- •Oral Preparations
- •Parenteral Preparations
- •Transdermal Preparations
- •Side Effects and Treatment Monitoring
- •Body Composition
- •Cognitive Decline
- •Bone Metabolism
- •The Kidneys
- •Endocrine Functions of the Kidney
- •Erythropoietin
- •Calcitriol
- •Renin
- •Paraneoplastic Syndromes
- •Hypercalcemia
- •Hypertension
- •Polycythemia
- •Other Endocrine Abnormalities
- •References
- •General Physiology
- •Prostate Innervation
- •Summary
- •References
- •Wound Healing
- •Inflammation
- •Proliferation
- •Remodeling
- •Principles of Plastic Surgery
- •Tissue Characteristics
- •Grafts
- •Flap
- •References
- •Lower Urinary Tract Symptoms
- •Storage Phase
- •Voiding Phase
- •Return to Storage Phase
- •Urodynamic Parameters
- •Urodynamic Techniques
- •Volume Voided Charts
- •Pad Testing
- •Typical Test Schedule
- •Uroflowmetry
- •Post Voiding Residual
- •Further Diagnostic Evaluation of Patients
- •Cystometry with or Without Video
- •Cystometry
- •Videocystometrography (Cystometry + Cystourethrography)
- •Cystometric Findings
- •Comment:
- •Measurements During the Storage Phase:
- •Measurements During the Voiding Phase:
- •Abnormal Function
- •Disorders of Sensation
- •Causes of Hypersensitive Bladder Sensation
- •Causes of Hyposensitive Bladder Sensation
- •Disorders of Detrusor Motor Function
- •Bladder Outflow Tract Dysfunction
- •Detrusor–Urethral Dyssynergia
- •Detrusor–Bladder Neck Dyssynergia
- •Detrusor–Sphincter Dyssynergia
- •Complex Urodynamic Investigation
- •Urethral Pressure Measurement
- •Technique
- •Neurophysiological Evaluation
- •Conclusion
- •References
- •Endoscopy
- •Cystourethroscopy
- •Ureteroscopy and Ureteropyeloscopy
- •Nephroscopy
- •Virtual Reality Simulators
- •Lasers
- •Clinical Application of Lasers
- •Condylomata Acuminata
- •Urolithiasis
- •Benign Prostatic Hyperplasia
- •Ureteral and Urethral Strictures
- •Conclusion
- •References
- •Introduction
- •The Prostatitis Syndromes
- •The Scope of the Problem
- •Category III CP/CPPS
- •The Goal of Treatment
- •Conservative Management
- •Drug Therapy
- •Antibiotics
- •Anti-inflammatories
- •Alpha blockers
- •Hormone Therapies
- •Phytotherapies
- •Analgesics, muscle relaxants and neuromodulators
- •Surgery
- •A Practical Management Plan
- •References
- •Orchitis
- •Definition and Etiology
- •Clinical Signs and Symptoms
- •Diagnostic Evaluation
- •Treatment of Infectious Orchitis
- •Epididymitis
- •Definition and Etiology
- •Clinical Signs and Symptoms
- •Diagnostic Evaluation of Epididymitis
- •Treatment of Acute Epididymitis
- •Treatment of Chronic Epididymitis
- •Treatment of Spermatic Cord Torsion
- •Fournier’s Gangrene
- •Definition and Etiology
- •Risk Factors
- •Clinical Signs and Symptoms
- •Diagnostic Evaluation
- •Treatment
- •References
- •Fungal Infections
- •Candidiasis
- •Aspergillosis
- •Cryptococcosis
- •Blastomycosis
- •Coccidioidomycosis
- •Histoplasmosis
- •Radiographic Findings
- •Treatment
- •Tuberculosis
- •Clinical Manifestations
- •Diagnosis
- •Treatment
- •Schistosomiasis
- •Clinical Manifestations
- •Diagnosis
- •Treatment
- •Filariasis
- •Clinical Manifestations
- •Diagnosis
- •Treatment
- •Onchocerciasis
- •References
- •25: Sexually Transmitted Infections
- •Introduction
- •STIs Associated with Genital Ulcers
- •Herpes Simplex Virus
- •Diagnosis
- •Treatment
- •Chancroid
- •Diagnosis
- •Treatment
- •Syphilis
- •Diagnosis
- •Treatment
- •Lymphogranuloma Venereum
- •Diagnosis
- •Treatment
- •Chlamydia
- •Diagnosis
- •Treatment
- •Gonorrhea
- •Diagnosis
- •Treatment
- •Trichomoniasis
- •Diagnosis
- •Treatment
- •Human Papilloma Virus
- •Diagnosis
- •Treatment
- •Scabies
- •Diagnosis
- •Treatment
- •References
- •26: Hematuria: Evaluation and Management
- •Introduction
- •Classification of Hematuria
- •Macroscopic Hematuria
- •Microscopic Hematuria
- •Dipstick Hematuria
- •Pseudohematuria
- •Factitious Hematuria
- •Menstruation
- •Aetiology
- •Malignancy
- •Urinary Calculi
- •Infection and Inflammation
- •Benign Prostatic Hyperplasia
- •Trauma
- •Drugs
- •Nephrological Causes
- •Assessment
- •History
- •Examination
- •Investigations
- •Dipstick Urinalysis
- •Cytology
- •Molecular Tests
- •Blood Tests
- •Flexible Cystoscopy
- •Upper Urinary Tract Evaluation
- •Renal USS
- •KUB Abdominal X-Ray
- •Intravenous Urography (IVU)
- •Computed Tomography (CT)
- •Retrograde Urogram Studies
- •Magnetic Resonance Imaging (MRI)
- •Additional Tests and Renal Biopsy
- •Intractable Hematuria
- •Loin Pain Hematuria Syndrome
- •References
- •27: Benign Prostatic Hyperplasia (BPH)
- •Historical Background
- •Pathophysiology
- •Patient Assessment
- •Treatment of BPH
- •Watchful Waiting
- •Drug Therapy
- •Interventional Therapies
- •Conclusions
- •References
- •28: Practical Guidelines for the Treatment of Erectile Dysfunction and Peyronie´s Disease
- •Erectile Dysfunction
- •Introduction
- •Diagnosis
- •Basic Evaluation
- •Cardiovascular System and Sexual Activity
- •Optional Tests
- •Treatment
- •Medical Treatment
- •Oral Agents
- •Phosphodiesterase Type 5 (PDE 5) Inhibitors
- •Nonresponders to PDE5 Inhibitors
- •Apomorphine SL
- •Yohimbine
- •Intracavernosal and Intraurethral Therapy
- •Intracavernosal Injection (ICI) Therapy
- •Intraurethral Therapy
- •Vacuum Constriction Devices
- •Surgical Therapy
- •Conclusion
- •Peyronie´s Disease (PD)
- •Introduction
- •Oral Drug Therapy
- •Intralesional Drug Therapy
- •Iontophoresis
- •Radiation Therapy
- •Surgical Therapy
- •References
- •29: Premature Ejaculation
- •Introduction
- •Epidemiology
- •Defining Premature Ejaculation
- •Voluntary Control
- •Sexual Satisfaction
- •Distress
- •Psychosexual Counseling
- •Pharmacological Treatment
- •On-Demand Treatment with Tramadol
- •Topical Anesthetics
- •Phosphodiesterase Inhibitors
- •Surgery
- •Conclusion
- •References
- •30: The Role of Interventional Management for Urinary Tract Calculi
- •Contraindications to ESWL
- •Complications of ESWL
- •PCNL Access
- •Instrumentation for PCNL
- •Nephrostomy Drains Post PCNL
- •Contraindications to PCNL
- •Complications of PCNL
- •Semirigid Ureteroscopy
- •Flexible Ureteroscopy
- •Electrohydraulic Lithotripsy (EHL)
- •Ultrasound
- •Ballistic Lithotripsy
- •Laser Lithotripsy
- •Ureteric Stents
- •Staghorn Calculi
- •Lower Pole Stones
- •Horseshoe Kidneys and Stones
- •Calyceal Diverticula Stones
- •Stones and PUJ Obstruction
- •Treatment of Ureteric Colic
- •Medical Expulsive Therapy (MET)
- •Intervention for Ureteric Stones
- •Stones in Pregnancy
- •Morbid Obesity
- •References
- •Anatomy and Function
- •Pathophysiology
- •Management
- •Optical Urethrotomy/Dilatation
- •Urethral Stents
- •Preoperative Assessment
- •Urethroplasty
- •Anastomotic Urethroplasty
- •Substitution Urethroplasty
- •Grafts Versus Flaps
- •Oral Mucosal Grafts
- •Tissue Engineering
- •Graft Position
- •Conclusion
- •References
- •32: Urinary Incontinence
- •Epidemiology and Risk Factors
- •Pathophysiology
- •Urge Incontinence
- •Conservative Treatments
- •Pharmacotherapy
- •Invasive/ Surgical Therapies
- •Stress Urinary Incontinence
- •Male SUI Therapies
- •Female SUI Therapies
- •Mixed Urinary Incontinence
- •Conclusions
- •References
- •33: Neurogenic Bladder
- •Introduction
- •Examination and Diagnostic Tests
- •History and Physical Examination
- •Imaging
- •Urodynamics (UDS)
- •Evoked Potentials
- •Classifications
- •Somatic Pathways
- •Brain Lesions
- •Cerebrovascular Accident (CVA)
- •Parkinson’s Disease (PD)
- •Multiple Sclerosis
- •Huntington’s Disease
- •Dementias
- •Normal Pressure Hydrocephalus (NPH)
- •Tumors
- •Psychiatric Disorders
- •Spinal Lesions and Pathology
- •Intervertebral Disk Prolapse
- •Spinal Cord Injury (SCI)
- •Transverse Myelitis
- •Peripheral Neuropathies
- •Metabolic Neuropathies
- •Pelvic Surgery
- •Treatment
- •Summary
- •References
- •34: Pelvic Prolapse
- •Introduction
- •Epidemiology
- •Anatomy and Pathophysiology
- •Evaluation and Diagnosis
- •Outcome Measures
- •Imaging
- •Urodynamics
- •Indications for Management
- •Biosynthetics
- •Surgical Management
- •Anterior Compartment Repair
- •Uterine/Apical Prolapse
- •Enterocele Repair
- •Conclusion
- •References
- •35: Urinary Tract Fistula
- •Introduction
- •Urogynecologic Fistula
- •Vesicovaginal Fistula
- •Etiology and Risk Factors
- •Clinical Factors
- •Evaluation and Diagnosis
- •Pelvic Examination
- •Cystoscopy
- •Imaging
- •Treatment
- •Conservative Management
- •Surgical Management
- •Urethrovaginal Fistula
- •Etiology and Presentation
- •Diagnosis and Management
- •Ureterovaginal Fistula
- •Etiology and Presentation
- •Diagnosis and Management
- •Vesicouterine Fistula
- •Etiology and Presentation
- •Diagnosis and Management
- •Uro-Enteric Fistula
- •Vesicoenteric Fistula
- •Pyeloenteric Fistula
- •Urethrorectal Fistula
- •References
- •36: Urologic Trauma
- •Introduction
- •Kidney
- •Expectant Management
- •Endovascular Therapy
- •Operative Intervention
- •Operative Management: Follow-up
- •Reno-Vascular Injuries
- •Pediatric Renal Injuries
- •Adrenal
- •Ureter
- •Diagnosis
- •Treatment
- •Delayed Diagnosis
- •Bladder and Posterior Urethra
- •Bladder Injuries: Initial Management
- •Bladder Injuries: Formal Repair
- •Anterior Urethral Trauma
- •Fractured Penis
- •Penile Amputation
- •Scrotal and Testicular Trauma
- •Imaging
- •CT-IVP (CT with Delayed Images)
- •Technique
- •Cystogram
- •Technique
- •Retrograde Urethrogram (RUG)
- •Technique
- •Retrograde Pyelogram (RPG)
- •Technique
- •One-Shot IVP
- •Technique
- •References
- •37: Bladder Cancer
- •Who Should Be Investigated?
- •Epidemiology
- •Risk Factors
- •Role of Screening
- •Signs and Symptoms
- •Imaging
- •Cystoscopy
- •Urine Tests
- •PDD-Assisted TUR
- •Pathology
- •NMIBC and Risk Groups
- •Intravesical Chemotherapy
- •Intravesical Immunotherapy
- •Immediate Cystectomy and CIS
- •Radical Cystectomy with Pelvic Lymph Node Dissection
- •sexual function-preserving techniques
- •Bladder-Preservation Treatments
- •Neoadjuvant Chemotherapy
- •Adjuvant Chemotherapy
- •Preoperative Radiotherapy
- •Follow-up After TUR in NMIBC
- •References
- •38: Prostate Cancer
- •Introduction
- •Epidemiology
- •Race
- •Geographic Variation
- •Risk Factors and Prevention
- •Family History
- •Diet and Lifestyle
- •Prevention
- •Screening and Diagnosis
- •Current Screening Recommendations
- •Biopsy
- •Pathology
- •Prognosis
- •Treatment of Prostate Cancer
- •Treatment for Localized Prostate Cancer (T1, T2)
- •Radical Prostatectomy
- •EBRT
- •IMRT
- •Brachytherapy
- •Treatment for Locally Advanced Prostate Cancer (T3, T4)
- •EBRT with ADT
- •Radical Prostatectomy
- •Androgen-Deprivation Therapy
- •Summary
- •References
- •39: The Management of Testis Cancer
- •Presentation and Diagnosis
- •Serum Tumor Markers
- •Primary Surgery
- •Testis Preserving Surgery
- •Risk Stratification
- •Surveillance Versus Primary RPLND
- •Primary RPLND
- •Adjuvant Treatment for High Risk
- •Clinical Stage 1 Seminoma
- •Risk-Stratified Adjuvant Treatment
- •Adjuvant Radiotherapy
- •Adjuvant Low Dose Chemotherapy
- •Primary Combination Chemotherapy
- •Late Toxicity
- •Salvage Strategies
- •Conclusion
- •References
- •Index
319
disordErs of scrotal contEnts
prediction of prognosis, counseling, and alloca- |
is anorectal or the wound is contaminated, a |
|||||||
tion of resources.109 |
|
|
|
colostomy should be performed to divert fecal |
||||
|
|
|
|
|
|
flow.100 In a likewise fashion, patients may |
||
Treatment |
|
|
|
|
|
require cystostomies for urinary diversion,espe- |
||
|
|
|
|
|
cially when there is a urinary source exacerbat- |
|||
|
|
|
|
|
|
|||
Treatment should include emergent radical sur- |
ing the necrotizing fasciitis. |
|||||||
Once the patient has been initially treated |
||||||||
gical debridement and intravenous broad-spec- |
||||||||
and resuscitated and all necrotic tissue has been |
||||||||
trum antibiotics. When |
culture results are |
|||||||
excised, most wounds can be closed secondarily. |
||||||||
available, the antibiotics can be tailored to the |
||||||||
Large wounds will often require skin grafts for |
||||||||
organisms based |
on sensitivities. Treatment |
|||||||
coverage. Fasciocutaneous rotational thigh flaps |
||||||||
should be performed expeditiously and aggres- |
||||||||
may be utilized for coverage with good cosmetic |
||||||||
sively, as Fournier’s gangrene is a life-threaten- |
||||||||
results.99 Wound closure is performed as soon |
||||||||
ing process. All nonviable and necrotic tissue |
||||||||
as there is no evidence of infection of remaining |
||||||||
must be aggressively excised (Fig. 23.6). |
|
|||||||
|
necrotic tissue, and there is a viable bed that |
|||||||
An empirical broad-spectrum antibiotic regi- |
||||||||
will allow |
reapproximation or grafting.100 |
|||||||
men for the initial treatment of Fournier’s gan- |
||||||||
Patients with less than 50% scrotal skin loss can |
||||||||
grene includes a third-generation cephalosporin, |
||||||||
almost always be closed primarily without |
||||||||
an aminoglycoside (if the creatinine clearance is |
||||||||
major difficulty. The testes may be placed in |
||||||||
acceptable), and metronidazole.Aggressive fluid |
||||||||
thigh pouches until the time of definitive recon- |
||||||||
resuscitation is required including the use of |
||||||||
struction in cases with major scrotal skin loss.110 |
||||||||
blood and blood products. After debridement, |
||||||||
Vacuum-assisted closure devices have been uti- |
||||||||
adequate nutrition with early |
enteral |
feeding |
||||||
lized to help these complex wounds heal after |
||||||||
when possible |
is |
crucial |
for |
wound |
healing. |
|||
wide excision and debridement. This technique |
||||||||
Repeat debridement should be performed 2 days |
||||||||
has been shown to be as effective as conven- |
||||||||
after the initial exploration to excise any remain- |
||||||||
tional wound care in healing wounds. These |
||||||||
ing nonviable tissue. Multiple resections may be |
||||||||
patients also |
require fewer dressing changes, |
|||||||
necessary. If |
the |
source |
of |
the infection |
||||
have less pain, fewer skipped meals, and greater mobility.111 The use of a small intestinal submucosa graft and fibrin sealant is an option for closure of scrotal defects after excision for Fournier’s gangrene when standard grafting is not possible.112
References
1. |
Delavierre D. Orchi-epididymitis. Ann Urol (Paris). |
|
2003;37(6):322-338 |
2. |
Gift TL,Owens CJ.The direct medical cost of epididym- |
|
itis and orchitis: evidence from a study of insurance |
|
claims. Sex Transm Dis. 2006;33(10 Suppl):S84-S88 |
3. |
Dogra V, Bhatt S. Acute painful scrotum. Radiol Clin |
|
North Am. 2004;42(2):349-363 |
4. |
Luker GD, Siegel MJ. Color Doppler sonography of the |
|
scrotum in children. AJR Am J Roentgenol. 1994;163: |
|
649-655 |
5. |
Lee JC, Bhatt S, Dogra VS. Imaging of the epididymis. |
|
Ultrasound Q. 2008;24(1):3-16 |
6. |
Dogra VS, Gottlieb RH, Oka M, Rubens DJ. Sonography |
|
of the scrotum. Radiology. 2003;227:18-36 |
7. |
Masarani M, Wazait H, Dinneen M. Mumps orchitis. J R |
Figure 23.6. aggressive debridement of fournier’s gangrene. |
Soc Med. 2006;99(11):573-575 |
320
Practical Urology: EssEntial PrinciPlEs and PracticE
8.Abdelbaky AM, Channappa DB, Islam S. Unilateral epididymo-orchitis: a rare complication of MMR vaccine. Ann R Coll Surg Engl. 2008;90(4):336-337
9.Wise GJ, Shteynshlyuger A.An update on lower urinary tract tuberculosis. Curr Urol Rep. 2008;9(4):305-313
10.Oğuzkurt P, Tanyel FC, Büyükpamukçu N. Acute scrotum due to edidymo-orchitis associated with vasal anomalies in children with anorectal malformations. J Pediatr Surg. 1998;33(12):1834-1836
11.Noske HD, Kraus SW, Altinkilic BM, Weidner W. Historical milestones regarding torsion of the scrotal organs. J Urol. 1998;159:13-16
12.Schuppe HC, Meinhardt A, Allam JP, Bergmann M, Weidner W,Haidl G.Chronic orchitis: a neglected cause of male infertility? Andrologia. 2008;40(2):84-91
13.Vaidyanathan S, Hughes PL, Mansour P, Soni BM. Seminoma of testis masquerading as orchitis in an adult with paraplegia: proposed measures to avoid delay in diagnosing testicular tumours in spinal cord injury patients. Sci World J. 2008;8:149-156
14.Cook JL, Dewbury K. The changes seen on highresolution ultrasound in orchitis. Clin Radiol. 2000;55: 13-18
15.Farriol VG, Comella XP, Agromayor EG, Creixams XS, Martinez De La Torre IB. Gray-scale and power Doppler sonographic appearances of acute inflammatory diseases of the scrotum. J Clin Ultrasound. 2000; 28:67-72
16.Horstman WG, Middleton WD, Melson GL. Scrotal inflammatory disease: color Doppler US findings. Radiology. 1991;179:55-59
17.Siegel MJ. The acute scrotum. Radiol Clin North Am. 1997;35:959-976
18.Tracy CR, Steers WD, Costabile R. Diagnosis and management of epididymitis. Urol Clin North Am. 2008;35(1):101-108
19.Collins MM, Stafford RS, O’Leary MP, et al. How common is prostatitis? A national survey of physician visits. J Urol. 1998;159:1224-1228
20.Moore CA, Lockett BL, Lennox KW, et al. Prednisone in the treatment of acute epididymitis: a cooperative study. J Urol. 1971;106:578-580
21.Tracy CR, Costabile RA. The evaluation and treatment of acute epididymitis in a large university based population: are CDC guidelines being followed? World J Urol. 2009;27(2):259-63
22.Tracy CR, Steers WD. Anatomy, physiology and diseases of the epididymis. AUA Update Series 2007; XXVI: lesson 12
23.Trei JS, Canas LC, Gould PL. Reproductive tract complications associated with Chlamydia trachomatis infection in US air force males within 4 years of testing. Sex Transm Dis. 2008;35(9):827-833
24.Nickel JC, Siemens DR, Nickel KR, Downey J. The patient with chronic epididymitis: characterization of an enigmatic syndrome. J Urol. 2002;167(4):1701-1704
25.Nickel JC, Teichman JM, Gregoire M, et al. Prevalence, diagnosis, characterization, and treatment of prostatitis, interstitial cystitis, and epididymitis in out patient urologic practice: the Canadian PIE study. Urology. 2005; 66:935-940
26.Heaton ND, Hogan B, Mitchell M, et al. Tuberculous epididymo-orchitis: clinical and ultrasound observations. Br J Urol. 1989;64:305-309
27.Pappas G,Akritidis N, Bostilkovski M, et al. Brucellosis. N Engl J Med. 2005;352:2325-2336
28.Ulbright TM, Amin MB, Young RH. Miscellaneous primary tumors of the testis, adnexa, and spermatic cord. In: Rosai J, Sobin LH, eds. Atlas of Tumor Pathology, fasc 25, ser 3. Washington, DC: Armed Forces Institute of Pathology; 1999:235-266
29.Ryan DM, Lesser BA, Crumley LA, et al. Epididymal sarcoidosis. J Urol. 1993;149(1):134-136
30.Cho YH, Lee KH, Band D, et al. Clinical features of patients with Behcet’s disease and epididymitis. J Urol. 2003;170(4):1231-1233
31.Gasparich JP, Mason JT, Greene HL, et al. Amiodaroneassociated epididymitis: drug-related epididymitis in the absence of infection. J Urol. 1985;133(6):971-972
32.Chiang IN, Chang SJ, Pu YS, Huang KH,Yu HJ, Huang CY. Major complications and associated risk factors of transrectal ultrasound guided prostate needle biopsy: a retrospective study of 1875 cases in Taiwan. J Formos Med Assoc. 2007;106(11):929-934
33.Somekh E, Gorenstein A, Serour F. Acute epididymitis in boys: evidence of a post-infectious etiology. J Urol. 2004;171(1):391-394
34.Lau P, Anderson PA, Giacomantonio JM, et al. Acute epididymitis in boys: are antibiotics indicated? Br J Urol. 1997;79:797-800
35.Huang LH, Yeung CY, Shyur SD, et al. Diagnosis of Henoch-Schonlein purpura by sonography and nuclear scanning in a child presenting with bilateral acute scrotum. J Microbiol Immunol Infect. 2004;37:192-195
36.Tracy CR,Costabile RA.The changing face of epididymitis from 1965 to 2005 [Abstract presentation, 53rd James C. Kimbrough Urological Seminar]
37.Hoppner W, Strohmeyer T, Hartmann M, LopezGamarra D, et al. Surgical treatment of acute epididymitis and its underlying diseases. Eur Urol. 1992;22: 218-221
38.Jantos C, Baumgartner W, Durchfield B, et al. Experimental epididymitis due to Chlamydia tracho matis in rats. Infect Immun. 1992;60(6):2324-2328
39.Calleary JG, Masood J, Hill JT. Chronic epididymitis: is epididymectomy a valid surgical treatment? Int J Androl. 2009;32(5):468-72
40.Haidl G, Allam JP, Schuppe HC. Chronic epididymitis: impact on semen parameters and therapeutic options. Andrologia. 2008;40(2):92-96
41.Al-Taheini KM, Pike J, Leonard M. Acute epididymitis in children: the role of radiologic studies. Urology. 2008;71(5):826-829
42.Korkowski KA, Berman SM. Sexually transmitted diseases treatment guidelines, 2006. MMWR Recomm Rep. 2006;5(RR11):1-94. doi:www.cdc.gov/std/treatment
43.Berger RE, Alexander ER, Harnisch JP, et al. Etiology, manifestations, and therapy of acute epididymitis: prospective study of 50 cases. J Urol. 1979;121:750-754
44.Pearson RC, Baumber CD, McGhie D, et al. The relevance of Chlamydia trachomatis in acute epididymitis in young men. Br J Urol. 1988;62:72-75
321
disordErs of scrotal contEnts
45.Grant JF, Costello CB, Sequeira PJ, et al. The role of
Chlamydia trachomatis in epididymitis. Br J Urol. 1987;60:355-359
46.Melekos M, Asbach H. Epididymitis: aspects concerning etiology and treatment. J Urol. 1987;138:83-86
47.Tracy R, Witmer MT, Costabile RA. The use of ultrasound in patients with clinical epididymitis in a university-based health care system. Poster presentation,65th Annual Mid-Atlantic Section of AUA; October 18–21, 2008; Southampton, Bermuda
48.Burke BJ, Parker SH, Hopper KD, et al. The ultrasonographic appearance of coexistent epididymal and testicular sarcoidosis. J Clin Ultrasound. 1990;18:522-526
49.Suzuki Y, Koike H, Tamura G, et al. Ultrasonographic findings of epididymal sarcoidosis. Urol Int. 1994;52: 228-230
50.Rudin L, Megalli M, Mesa-Tejada R. Genital sarcoidosis. Urology. 1974;3(6):750-754
51.Packel LJ, Guerry S, Bauer HM, et al. Patient-delivered partner therapy for chlamydial infections: attitudes and practices of California physicians and nurse practitioners. Sex Transm Dis. 2006;33(7):458-463
52.Davis BE, Noble MJ. Analysis and management of chronic orchalgia. AUA Update Series 1992; XI: lesson 2
53.Mittemeyer BT, Lennox KW, Borski AA. Epididymitis: a review of 610 cases. J Urol. 1966;95:390-392
54.Davis BE, Noble KJ, Weigel JW. Analysis and management of chronic testicular pain. J Urol. 1990;143:936
55.Chen TF, Ball RY. Epididymectomy for post-vasectomy pain: histological review. BJU Int. 1991;68:407
56.Padmore DE, Norman RW, Millard OH. Analyses of
indications for and outcomes of epididymectomy.
J Urol. 1996;156:95
57.Strom KH, Levine LA. Microsurgical denervation of the spermatic cord for chronic orchialgia: long-term results from a single center. J Urol. 2008;180(3):949-953
58.Arbuliev MG, Arbuliev KM, Gadzhiev DP, Abunimekh BKh. [Diagnosis and treatment of acute epididymo orchitis]. Urologiia. 2008;(3):49-52
59.Svetec DA,Waguespack RL,Sabanegh ES Jr.Intermittent azoospermia associated with epididymal sarcoidosis. Fertil Steril. 1998;70(4):777-779
60.Al-Ghazo MA, Bani-Hani KE, Amarin ZO. Tuberculous epididymitis and fertility in North Jordan. Saudi Med J. 2005;26(8):1212-1215
61.Hinzes JD, Winn RE. Tuberculosis of theurogenital tract. Infectious diseases. 2nd edition. Mosby: An Imprint of Elsevier; 2004:773–7
62.Solera J, Geijo P, Largo J, et al. Grupo de Estudio de Castilla-la Mancha de Enfermedades Infecciosas. A randomized, double-blind study to assess the optimal duration of doxycycline treatment for human brucellosis. Clin Infect Dis. 2004;39(12):1776-1782
63.Liu CC, Huang SP, Chou YH, et al. Clinical presentation of acute scrotum in young males. Kaohsiung J Med Sci. 2007;23(6):281-286
64.Ringdahl E, Teague L. Testicular torsion. Am Fam Physician. 2006;74(10):1739-1743
65.Williamson RC. Torsion of the testis and allied conditions. Br J Surg. 1976;63:465-476
66.Washowich L. Synchronous bilateral testicular torsion in an adult. J Ultrasound Med. 2001;20:933-935
67.Rabinowitz R. The importance of the cremasteric reflex in acute scrotal swelling in children. J Urol. 1984;132: 89-90
68.Dogra V, Ledwidge ME, Winter TC III, Lee FT Jr. Bell-clapper deformity. Am J Roentgenol. 2003;180: 1176-1177
69.Kapoor S. Testicular torsion: a race against time. Int J Clin Pract. 2008;62(5):821-827
70.Herbener TE. Ultrasound in the assessment of the acute scrotum. J Clin Ultrasound. 1996;24:405-421
71.Hayn MH, Herz DB, Bellinger MF, Schneck FX. Intermittent torsion of the spermatic cord portends an increased risk of acute testicular infarction. J Urol. 2008;180(4 Suppl):1729-1732
72.Eaton SH, Cendron MA, Estrada CR, et al. Intermittent testicular torsion: diagnostic features and management outcomes. J Urol. 2005;174(4 Pt2):1532-1535. discussion1535
73.Mor Y, Pinthus JH, Nadu A, et al. Testicular fixation following torsion of the spermatic cord-does it guarantee prevention of recurrent torsion events? J Urol. 2006; 175(1):171-173; discussion 173-174
74.Backhouse K. Embryology of testicular descent and maldescent. Urol Clin North Am. 1982;9:315-325
75.Hawtrey CE. Assessment of acute scrotal symptoms and findings: a clinician’s dilemma. Urol Clin North Am. 1998;25:715-723
76.Brown SM, Casillas VJ, Montalvo BM,Albores-Saavedra J. Intrauterine spermatic cord torsion in the newborn: sonographic and pathologic correlation. Radiology. 1990;177:755-757
77.Ahmed SJ, Kaplan GW, DeCambre ME. Perinatal testicular torsion: preoperative radiological findings and the argument for urgent surgical exploration. J Pediatr Surg. 2008;43(8):1563-1565
78.Kaye JD, Levitt SB, Friedman SC, Franco I, Gitlin J, Palmer LS. Neonatal torsion: a 14-years experience and proposed algorithm for management. J Urol. 2008; 179(6): 2377-2383
79.Zilberman D, Inbar Y, Heyman Z, et al. Torsion of the cryptorchid testis–can it be salvaged? J Urol. 2006; 175(6): 2287-2289
80.Dubinsky TJ, Chen P, Maklad N. Color-flow and power Doppler imaging of the testes. World J Urol. 1998;16: 35-40
81.Lerner RM, Mevorach RA, Hulbert WC, Rabinowitz R. Color Doppler US in the evaluation of acute scrotal disease. Radiology. 1990;176:355-358
82.Luker GD, Siegel MJ. Scrotal US in pediatric patients: comparison of power and standard color Doppler US. Radiology. 1996;198:381-385
83.Watanabe Y, Nagayama M, Okumura A, et al. MR imaging of testicular torsion: features of testicular hemorrhagic necrosis and clinical outcomes. J Magn Reson Imaging. 2007;26(1):100-108
84.Rakha E, Puls F, Saidul I, Furness P. Torsion of the testicular appendix: importance of associated acute inflammation. J Clin Pathol. 2006;59(8):831-834
322
Practical Urology: EssEntial PrinciPlEs and PracticE
85.Skoglund RW, McRoberts JW, Ragde H. Torsion of testicular appendages: presentation of 43 new cases and a collective review. J Urol. 1970;104:598-600
86.Yang DM, Lim JW, Kim JE, Kim JH, Cho H. Torsed appendix testis: gray scale and color Doppler sonographic findings compared with normal appendix testis. J Ultrasound Med. 2005;24(1):87-91
87.Patriquin HB, Yazbeck S, Trinh B, et al. Testicular torsion in infants and children: diagnosis with Doppler sonography. Radiology. 1993;188:781-785
88.Mansbach JM, Forbes P, Peters C. Testicular torsion and risk factors for orchiectomy. Arch Pediatr Adolesc Med. 2005;159(12):1167-1171
89.Taskinen S, Taskinen M, Rintala R. Testicular torsion: orchiectomy or orchiopexy? J Pediatr Urol. 2008;4(3): 210-213
90.Guerra LA, Wiesenthal J, Pike J, Leonard MP. Management of neonatal testicular torsion: which way to turn? Can Urol Assoc J. 2008;2(4):376-379
91.Al-Salem AH. Intrauterine testicular torsion: a surgical emergency. J Pediatr Surg. 2007;42(11):1887-1891
92.Arap MA, Vicentini FC, Cocuzza M, et al. Late hormonal levels, semen parameters, and presence of antisperm antibodies in patients treated for testicular torsion. J Androl. 2007;28(4):528-532
93.Elem B, Ranjan P. Impact of immunodeficiency virus (HIV) on Fournier’s gangrene: observations in Zambia.
Ann R Coll Surg Engl. 1995;77:283-286
94.Kabay S, Yucel M, Yaylak F, et al. The clinical features of Fournier’s gangrene and the predictivity of the Fournier’s gangrene severity index on the outcomes. Int Urol Nephrol. 2008;40(4):997-1004
95.Vick R, Carson CC III. Fournier’s disease. Urol Clin North Am. 1999;26:841-849
96.Vaz I. Fournier gangrene. Trop Doct. 2006;36(4): 203-204
97.Grinev MV, Soroka IV, Grinev KM. [Fournier’s gangrene – a model of necrotizing fasciitis (clinical and pathogeneticaspects)].Urologiia.November-December 2007;(6):69–73
98.Cakmak A, Genç V, Akyol C, Ayhan Kayaoğlu H, Hazinedaroğlu SM. Fournier’s gangrene: is it scrotal gangrene? Adv Ther. 2008;25(10):1065-1074
99.Bhatnagar AM, Mohite PN, Suthar M. Fournier’s Gangrene: a review of 110 cases for aetiology, predis-
posing conditions, microorganisms, and modalities for coverage of necrosed scrotum with bare testes. NZ Med J. 2008;121(1275):46-56
100.Ghnnam WM. Fournier’s gangrene in Mansoura Egypt: a review of 74 cases. J Postgrad Med. 2008;54(2): 106-109
101.Kuo CF,Wang WS, Lee CM, Liu CP, Tseng HK. Fournier’s gangrene: 10-years experience in a medical center in northern Taiwan. J Microbiol Immunol Infect. 2007; 40(6):500-506
102.Urdaneta Carruyo E, Méndez Parra A, Urdaneta Contreras AV. Fournier’s gangrene current perspectives. An Med Interna. 2007;24(4):190-194
103.Gupta A, Dalela D, Sankhwar SN, et al. Bilateral testicular gangrene: does it occur in Fournier’s gangrene? Int Urol Nephrol. 2007;39(3):913-915
104.Benizri E, Fabiani P, Migliori G, et al. Gangrene of the perineum. Urology. 1996;47:935-939
105.Loulergue P, Mahe V, Bougnoux ME, Poiree S, Hot A, Lortholary O. Fournier’s gangrene due to Candida glabrata. Med Mycol. 2008;46(2):171-173
106.Dogra VS, Smeltzer JS, Poblette J. Sonographic diagnosis of Fournier’s gangrene. J Clin Ultrasound. 1994; 22:571-572
107.Levenson RB, Singh AK, Novelline RA. Fournier gangrene: role of imaging. RadioGraphics. 2008;28(2): 519-528
108.Corcoran AT, Smaldone MC, Gibbons EP, Walsh TJ, Davies BJ. Validation of the Fournier’s gangrene severity index in a large contemporary series. J Urol. 2008; 180(3):944-948
109.Laor E, Palmer LS, Tolia BM, Reid RE, Winter HI. Outcome prediction in patients with Fournier’s gangrene. J Urol. 1995;154(1):89-92
110.Gudaviciene D, Milonas D. Scrotal reconstruction using thigh pedicle flaps after scrotal skin avulsion. Urol Int. 2008;81(1):122-124
111.Ozturk E, Ozguc H, Yilmazlar T. The use of vacuum assisted closure therapy in the management of Fournier’s gangrene. Am J Surg. 2009;197(5):660-5; discussion 665
112.Kavoussi PK, Bird ET. Repair of a scrotal wound defect after Fournier’s gangrene: a novel approach. Issues Urol. 2007;19(2):75-77